Prognostic value of lymph node ratio in metastatic papillary thyroid carcinoma

J. Mansour*, D. Sagiv, E. Alon, Y. Talmi

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

50 Scopus citations


Objective: Cervical metastases in papillary thyroid carcinoma are associated with increased recurrence. However, their effect on survival remains controversial. This study evaluated literature on the prognostic value of lymph node ratio for loco-regional recurrence and survival in metastatic papillary thyroid carcinoma. Methods: The PubMed database was systematically searched using the terms 'papillary thyroid carcinoma' and 'lymph node ratio'. Articles addressing the association between lymph node ratio and loco-regional recurrence or survival were identified. Results: Nine retrospective studies were included, comprising 12 400 post-thyroidectomy and neck dissection papillary thyroid carcinoma patients (median age, 48.6 years; 76 per cent females). Lymph node ratio was associated with worse recurrence-free survival in 60 and 75 per cent of studies investigating the effect of central compartment metastases and both central and lateral compartment metastases on recurrence-free survival, respectively. One large population-based study showed an association between lymph node ratio and disease-specific mortality in N1 nodal disease, but failed to maintain the same association when N1b patients were excluded. Conclusion: Regional lymph node ratio is an independent predictor for loco-regional recurrence in pathologically staged N1 patients with papillary thyroid carcinoma. Patients with a high lymph node ratio should be closely followed up.

Original languageEnglish
Pages (from-to)8-13
Number of pages6
JournalJournal of Laryngology and Otology
Issue number1
StatePublished - 1 Jan 2018


  • Carcinoma
  • Lymph Nodes
  • Neck Dissection
  • Neoplasm Metastasis
  • Papillary
  • Thyroid Cancer


Dive into the research topics of 'Prognostic value of lymph node ratio in metastatic papillary thyroid carcinoma'. Together they form a unique fingerprint.

Cite this